Dr. Geetha Sagar Manikonda, MD

Dr. Manikonda practices at Frederick Health Hospital in Frederick, Maryland, part of Frederick Health.

Dr. Manikonda's NPI, 1538423199, was assigned on June 28, 2012. Dr. Manikonda holds Maryland license D79401.

Dr. Manikonda's primary practice is Frederick Health Hospital, at 400 West Seventh St, Frederick, MD 21701 in Frederick County. The practice phone is (240) 566-3300.

Dr. Manikonda's primary practice is Frederick Health Hospital in Frederick, Maryland, part of Frederick Health. Dr. Manikonda is also affiliated with The George Washington University Hospital. The medical group on file is Hospitalist Medicine Physicians of Maryland PC. Dmand AI also links Dr. Manikonda to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manikonda practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Manikonda's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Manikonda is licensed in Maryland.

CMS data shows 1,728 Medicare services from Dr. Manikonda across 6 procedure codes in 2024, for 511 Medicare patients. Medicare paid $155,286 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 511 Medicare patients who saw Dr. Manikonda in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Manikonda's median patient age at 67, with 49% women.

In 2024, Dr. Manikonda wrote 350 Medicare Part D claims for 157 patients. 85% of them were for generic drugs. CMS names the drug for 122 of them, across 8 drugs with 11 or more claims each, at $475 in total drug cost. In 2023, CMS named 171 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Manikonda for performance year 2024, reported through an alternative payment model (APM). Dr. Manikonda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Dr. Manikonda from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $102.